EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY-NC 4.0

Impaired Sleep in Patients with Post-COVID-19 Syndrome Compared to Healthy Controls: A Cross-Sectional Trial

Inga Jarosch, Tessa Schneeberger, Antje Stegemann, Rainer Gloeckl, Daniela Leitl, Clancy Dennis, Wolfgang Hitzl, Christopher Schoen, Andreas Rembert Koczulla

Respiration · 2024 · 103 (4) · 177-181

DOI: 10.1159/000536272 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Respiration, online erschienen am 01.03.2024. Verfasst von Inga Jarosch und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Pulmonary Rehabilitation Research, Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany. Hauptthemen laut MEDLINE: COVID-19, Sleep Apnea Syndromes, Sleep Apnea, Obstructive. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

To objectify self-reported sleep disorders in individuals with post-COVID-syndrome (PCS), we aimed to investigate the prevalence and nature of sleep disturbances by polysomnography (PSG) in PCS compared to healthy individuals.

Methods

People with PCS (n = 21) and healthy controls (CON, n = 10) were included in this prospective trial. At baseline, clinical and social anamnesis, lung function, 1 min sit-to-stand test (STST) and Pittsburgh Sleep Quality Index (PSQI) were assessed. For a single-night, sleep health was evaluated by video-PSG. The apnoea/hypopnea index (AHI) was used as the primary outcome.

Results

Twenty patients with PCS (50 ± 11 y, BMI 27.1 m2/kg, SARS-CoV-2 infection 8.5 ± 4.5 months ago) and 10 CON participants (46 ± 10 y, BMI 23.0 m2/kg, no SARS-CoV-2 infection in the history) completed the study. Forced vital capacity (p = 0.018), STST repetitions (p < 0.001), and symptoms of dyspnoea (at rest: p = 0.002, exertion: p < 0.001) were worse in PCS compared to CON. PSQI score (PCS: 7.5 ± 4.7 points) was higher in PCS compared to CON (Δ = 3.7 points, 95% CI [0.4–7.1] p = 0.015), indicating poor sleep in 80% of patients with PCS. Although PSG showed comparable sleep stage distributions in both groups, AHI (Δ = 9.0 n/h, 95% CI [3.3–14.8], p = 0.002), PLM index (Δ = 5.1 n/h, 95% CI [0.4–9.8], p = 0.017), and the prevalence of sleep apnoea (60% vs. 10%, p = 0.028) was significantly higher in PCS compared to CON.

Conclusion

Quantifiable subjective limitations of sleep have been revealed by PSG data in this PCS cohort. More than half of PCS patients had signs of sleep apnoea, highlighting the importance of sleep screening in PCS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Sleep Apnea SyndromesSleep Apnea, ObstructiveHumansCross-Sectional StudiesPost-Acute COVID-19 SyndromeProspective StudiesSARS-CoV-2SleepAdultMiddle Aged

Stichwörter der Autor:innen

Periodic leg movementPolysomnographySleep and breathingSleep apnoea

Autor:innen und Institutionen

  • Institute for Pulmonary Rehabilitation Research, Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany.
  • Department of Pulmonary Rehabilitation, Philipps-University of Marburg, German Center for Lung Research (DZL), Marburg, Germany.
  • The University of Sydney, Faculty of Medicine and Health Science, Sydney, New South Wales, Australia.
  • Zamanian Lab, Department of Pulmonary and Critical Care Medicine, Stanford University, Stanford, California, USA.
  • Research Program Experimental Ophthalmology and Glaucoma Research, Paracelsus Medical University, Salzburg, Austria.
  • Research and Innovation Management (RIM), Team Biostatistics and publication of clinical trial studies/machine learning, Paracelsus Medical University (PMU), Salzburg, Austria.

Zitieren

APA

Jarosch, I., Schneeberger, T., Stegemann, A., Gloeckl, R., Leitl, D., Dennis, C., Hitzl, W., Schoen, C., & Koczulla, A. R. (2024). Impaired Sleep in Patients with Post-COVID-19 Syndrome Compared to Healthy Controls: A Cross-Sectional Trial. Respiration, 103(4), 177-181. https://doi.org/10.1159/000536272

Vancouver

Jarosch I, Schneeberger T, Stegemann A, Gloeckl R, Leitl D, Dennis C, et al. Impaired Sleep in Patients with Post-COVID-19 Syndrome Compared to Healthy Controls: A Cross-Sectional Trial. Respiration. 2024;103(4):177-181. doi:10.1159/000536272

BibTeX
@article{Jarosch2024,
  author = {Jarosch, Inga and Schneeberger, Tessa and Stegemann, Antje and Gloeckl, Rainer and Leitl, Daniela and Dennis, Clancy and Hitzl, Wolfgang and Schoen, Christopher and Koczulla, Andreas Rembert},
  title = {Impaired Sleep in Patients with Post-COVID-19 Syndrome Compared to Healthy Controls: A Cross-Sectional Trial},
  journal = {Respiration},
  year = {2024},
  volume = {103},
  number = {4},
  pages = {177--181},
  doi = {10.1159/000536272}
}
Kostenlos starten →